Clinical and Translational Science Institute

Centers

7-1-2018

Preeclampsia and the 20th century: "Le siècle des Lumières"
Pierre-Yves Robillard
Centre d’Etudes Périnatales Océan Indien

Gustaaf Dekker
University of Adelaide

Gérard Chaouat
Hôpital Saint-Louis

Philippe Le Bouteiller
INSERM UMR 1043, F-31300 Toulouse, France

Marco Scioscia
Ospedale Sacro Cuore Don Calabria

See next page for additional authors

Follow this and additional works at: https://researchrepository.wvu.edu/ctsi
Part of the Medicine and Health Sciences Commons

Digital Commons Citation
Robillard, Pierre-Yves; Dekker, Gustaaf; Chaouat, Gérard; Le Bouteiller, Philippe; Scioscia, Marco; and
Hulsey, Thomas C., "Preeclampsia and the 20th century: "Le siècle des Lumières"" (2018). Clinical and
Translational Science Institute. 964.
https://researchrepository.wvu.edu/ctsi/964

This Article is brought to you for free and open access by the Centers at The Research Repository @ WVU. It has
been accepted for inclusion in Clinical and Translational Science Institute by an authorized administrator of The
Research Repository @ WVU. For more information, please contact ian.harmon@mail.wvu.edu.

Authors
Pierre-Yves Robillard, Gustaaf Dekker, Gérard Chaouat, Philippe Le Bouteiller, Marco Scioscia, and Thomas
C. Hulsey

This article is available at The Research Repository @ WVU: https://researchrepository.wvu.edu/ctsi/964

HHS Public Access
Author manuscript
Author Manuscript

Pregnancy Hypertens. Author manuscript; available in PMC 2019 July 01.
Published in final edited form as:
Pregnancy Hypertens. 2018 July ; 13: 107–109. doi:10.1016/j.preghy.2018.05.013.

Preeclampsia and the 20th century: “Le siècle des Lumières”
Pierre-Yves Robillarda,*, Gustaaf Dekkerb, Gérard Chaouatc, Philippe Le Bouteillerd,e,
Marco Sciosciaf, and Thomas C. Hulseyg
aNeonatology,

Centre Hospitalier Universitaire Réunion, Centre d’Etudes Périnatales Océan
Indien, BP 350, 97448 Saint-Pierre cedex, Réunion, France

bHead

Author Manuscript

Women’s and Children’s Division, Lyell McEwin Hospital, University of Adelaide, Haydown
Road, Elizabeth Vale, 5112 South Australia, Australia

cINSERM

U 976, Pavillon Bazin, Hôpital Saint-Louis, 75010 Paris, France

dINSERM

UMR 1043, F-31300 Toulouse, France

eCNRS,

UMR 5282, F-31300 Toulouse, France

fDepartment

of Obstetrics and Gynaecology, Sacro Cuore Don Calabria, Negrar, Verona, Italy

gDepartment

of Epidemiology, School of Public Health, West Virginia University, United States

SUMMARY
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The authors delineate seven quantum leap forward and, or revolutions having occurred during the
20th century in the understanding of the physiopathology of preeclampsia. First the discovery of
the inflatable arm band permitting to measure blood pressure in 1896. Second, the discovery that
eclamptic (convulsions), and later “pre”eclamptic (proteinuria) women presented hypertension in
1897 and confirmed in 1903, discovery of the hypertensive disorders of pregnancy. Third, the eight
major textbooks published all along the 20th century by delineating risk factors of preeclampsia
with the concept of “preeclampsia, disease of primigravidae”. Fourth, the discovery in the 1970’s
that human trophoblast implantation was far deeper than in other mammalian species. Fifth, and a
major step forward, description at the end of the 1980’s that the maternal syndrome in
preeclampsia (glomeruloendotheliosis, HELLP syndrome, eclampsia) could be unified in a global
endothelial cell inflammation. Sixth, the epidemiological descriptions in the 1970–1990’s that
indeed preeclampsia was a disease of first pregnancies at the level of a couple (“primipaternity
concept”), leading to an explosion in immunological research in the last decade, beginning in
1998. Seventh and finally, in the search for the “factor X” explaining the vascular inflammation in
preeclamptic women (inositol phospho glycans P-type were described in 2000, while soluble Flt-1
and S-endoglins have been clearly predicted since 1997). The majority of the seeds or findings
have been grounded or realized in the 20th century. Indeed, for preeclampsia, the 20th century has
been le “Siècle des Lumières” (the Enlightments).
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In a prestigious end-of-20th century (1997) statement of the art on preeclampsia [1], one
could read: “Early scholars, having made some very accurate descriptions of pre-eclampsia/
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eclampsia…raised the notion that this disorder is due to a toxin, and realized that delivery
was the only cure, would be disappointed to watch us approach the end of this century with
few further advances.” [1]. This pessimistic comment may deserve today a response
according to the current comprehension of this strange disease, a plague apparently specific
of human reproduction, since we are probably closer than ever before to come to a full
comprehension of its mechanisms. Indeed, we wish to propose that the 20th century has
been the one to understand many clues and when very important quantum leap forwards and
major steps occurred in such a process.

Author Manuscript
Author Manuscript

The first 20th century’s revolution was invention in 1896 of the inflatable arm-band, with
immeasurable consequences, by a 33 year old Italian physician, Riva-Rocci, permitting to
measure blood pressure on a daily clinical practice in all patients [2]. Second and
consequently, very quickly, after Vaquez in 1897, in 1903, two American obstetricians,
Cooks and Briggs described that eclamptic patients presented abnormal high systolic
pressure at delivery (the measurement of diastolic pressure has been accomplished only in
1906 by Korotkoff). Very soon after, it has been verified that hypertension existed also in
“pre”-eclamptic patients. Existence of a proteinuria in pregnant patients, often associated
with edemas had been known since the 1840’s, and it had been well noticed that these
patients were the ones at risk of eclampsia in approximately 1/3 of cases) [2]. Moreover,
there was also the discovery that pregnant women could present a pregnancy-transienthypertension without necessarily evolving towards preeclampsia. The well-known eclampsia
(convulsion, with a specific interest on women giving birth, likely the first human disease
ever described in writings of all cultures, and in all continents, since their beginning 5000
years ago) [2] has been understood by then to be literally the tip of an iceberg (1/10): the
hypertensive disorders of pregnancy (HDP). In this light, by its discovery, pregnancy
associated hypertension, and pre eclampsia although having always existed in humans may
be considered as a “20th century disease”.
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A third 20th century’s paramount step was when the obstetricians confronted with the
“gestational hypertension” problem had no other resources than to compellingly and
patiently accumulate clinical evidences and delineate epidemiological risk factors
differentiating preeclampsia from essential hypertension. And, indeed, our masters did a
“pharaonic” work, regularly summarized in the major textbooks all along the century
(Kosmak, 1931; Dieckmann, 1952; Davies, 1971; Chesley, 1978; MacGillivray, 1983;
Lindheimer & Chesley, 1999) [2–8]. This led to the 20th century’s dogma: Preeclampsia
(and HDP) is a “disease of primigravidae”. This is also summarized by Leon Chesley’s
testament in 2000 when he stated in a paper published a few weeks after his death [9]: “I
would suggest that Editors reject any study of preeclampsia that includes multiparous unless
they are analyzed separately”, emphasized by the Editor’s comment: « Eclampsia and ‘true’
preeclampsia are chiefly diseases of primiparous women, whereas in multiparous women
eclampsia is more likely associated with underlying chronic hypertension ». This statement
finalized the loop initiated in the 17th century concerning eclampsia by Mauriceau (“Traité
des femmes grosses”, 1694): “primiparae are by far at more risk of convulsions than do
multiparae” [2].
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The fourth 20th century’s revolution: the discovery in the 1970’s initiated by Brosens &
Renaer [10] and established by Pijnenborg & Brosens [11,12] that humans among the 4300
different mammalian species were likely the ones who presented the deepest trophoblastic
invasion in a far longer process than most of other haemochorial placentae (until the end of
first trimester of pregnancy, at 14–16th week gestation, i.e. 1/3 of gestation!). Moreover, this
happens with an haemochorial placenta and thus establishes intimate cellular relationships
between the mother’s tissues and the –physiologically– half foreign trophoblast (“semiallograft”). A key point was that in preeclampsia (in particular when associated with intra
uterine growth retardation) this deep implantation was deficient (“shallow invasion”
concept). This allowed to understand two major issues: a) hypertension in women was then
seen as a compensatory mechanism to try to overlap the shallow implanted placenta and
deliver the maximum of nutrients to the foetus and b) this quasi-human specificity explained
why there was so far no fully satisfactory natural animal model for eclampsia/preeclampsia
in other mammals, as the status of the great apes in that respect remains nowadays poorly
explored.
A fifth 20th century’s paramount advance was the discovery by Roberts, Taylor and Redman
[13,14] that almost all, if not all maternal manifestations in preeclampsia are due to a global
endothelial cell disease, in particular affecting specialised endothelial cells: glomerulus
(glomeruloendotheliosis), hepatic Kupfer cells (HELLP syndrome) and cerebral choroid
plexus cells (eclampsia). It was then the Oxford group demonstrating that this endothelial
cell dysfunction was part of a more systemic maternal inflammatory syndrome [15].
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The sixth 20th century’s revolution occurred in the late 1970’s, and the data were confirmed
in the mid-1990’s: a protective effect of a first pregnancy against subsequent reoccurrence
was described. Moreover, HDP were much less prominent in primigravid women who
conceived after a period of long sexual cohabitation by Marti & Herrman in 1977 [16]. In
the same vein (Lancet, October 8th, 1994) [17], these complications have been described in
women with a short period of sexual cohabitation such as multi-gravid women who have
changed their male partner, these women displaying the same disease patterns those of
primigravidae [17,18]. These facts suggested that HDP/preeclampsia were in fact also a
“couple disease” [19]. It is therefore a disease of first pregnancy in new couples, e.g. if a
multiparous woman changes her male partner, she has the same risk as a primigravid
woman. This led to the primipaternity concept [20]. The Sixth 20th century’s major step
forwards were key discoveries in immunology of reproduction (see Table 1). The evidences
that uterus is immunologically prepared to implantation by the paramount and unexpected
immunological properties of the seminal fluid by Sarah Roberston’s team in Adelaide,
Australia, dates from 1998 [21]. Furthermore, the discovery occurring “like a thunderstorm
in a quiet sky” that Natural Killer cells were key regulators of an adequate implantation/
invasion of the trophoblast and transformation of uterine vessels into spiral arteries by Ann
Croy and al dates from 2000 (and the year 2000 still belongs to the 20th century) [22], later
confirmed in humans [23].
Seventh, and finally was the search of the possible cause(s) leading to the global endothelial
cell disease in mothers and thus explaining all cases of preeclampsia. As a matter of fact, to
date a consensus has raised amongst researchers in PE: if there are immunological
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implications in the etiology of PE “placental preeclampsia”, all PE features cases cannot be
explained solely by immunology (paternity). Many women present this syndrome because
they have vascular predispositions (“maternal syndrome” concept). In this domain again,
many seeds have been grounded before the turn of the 20th century. For example, important
molecules which are still explored in 2018 have been already described such as the inositol
phopshoglycan P- type described at first by Kunjara et al in 2000 [24–27], or soluble
endoglins and soluble Flt-1 also well-known to be present in maternal bloodstream in
preeclampia (2004) [28], have well been predicted at the end of the 20th century as major
candidates [29].
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To date, in the 21st century, one may feel that we are seriously approaching the answer to
the preeclampsia puzzle, ninety per cent of the seeds or findings having been grounded or
realized in the 20th century. Indeed, for preeclampsia, the 20th century has been le “Siècle
des Lumières” (the Enlightments).
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Roberts, Taylor, Redman 1989 [13–15]
Summarized in Robillard et al 2011 [30]
Redman & Sargent 2010 [31]

IPG-P Kunjara (2000) [24,25], Soluble Flt-1 Ahmed
1997, Levine & Karumantchi 2004 [28,29]

Major advances in Immunology of Reproduction
• Lack of HLA-G in PE (1990’s)
• Role of cytokines (Th1/Th2 paradigm) (1990’s)
• Immunological role of seminal fluid (TGF β) Tremelen & Sarah Robertson (1998)
• Pivotal role of NK cells (implantation and angiogenesis)
• B.A. Croy, A. Moffett, S. Hiby (2000–2004)
• Dysregulation of angiogenic factors by complement activation Girardi et al JEM 2006 203(9):2165–75.
• Role of hyperglycosylated HCG (deepness of implantation) (≈2007), Laurence Cole.
• Immunological animal model for PE (Girardi, 2008)
• Pivotal role of T Reg cells (≈2010’s)

In the search of the “Factor X” (cause of the global endothelial cell disease)

Pijnenborg & Brosens [10–12]

Discovery of the unique human feature of invasivness of the trophoblast (the so-called 2nd trophoblastic invasion at the end of the 1st trimester
of pregnancy)

Epidemiological challenge of “preeclampsia, disease of primiparae”. Description of preeclampsia being a disease of first pregnancies at a level
of a couple (“primipaternity model”)

Kosmak, 1931; Dieckmann, 1952; Davies, 1971;
Chesley, 1978; MacGillivray, 1983; Lindheimer &
Chesley, 1999 [2–8]

Numerous Epidemiological descriptions of risk factors of preeclampsia (major textbooks). “preeclampsia, disease of primigravidae)

Preeclampsia as a global endothelial cell disease

Cooks & Briggs 1903 (discovery of the inflatable arm
band in 1896, by Riva Rocci) [2]

Discovery of gestational hypertension in eclamptic women, confirmed afterwards in preeclamptic women

Summary of several historical advances in comprehension of preeclampsia.
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